SPI Pharma Corp Ad SPI Pharma Corp Ad

X

CAS 27143-07-3 manufacturers and suppliers on PharmaCompass

PharmaCompass
Ethyl(2Z)-chloro((4-methoxyphenyl)hydrazono)acetate
Also known as: 27143-07-3, Ethyl chloro[(4-methoxyphenyl)hydrazono]acetate, Ethyl (2z)-2-chloro-2-[(4-methoxyphenyl)hydrazinylidene]acetate, Ethyl 2-chloro-2-(2-(4-methoxyphenyl)hydrazono)acetate, 473927-63-8, Ethyl chloro((4-methoxyphenyl)hydrazono)acetate
Molecular Formula
C11H13ClN2O3
Molecular Weight
256.68  g/mol
InChI Key
ATNPZEGMKLGIFA-UVTDQMKNSA-N

1 2D Structure

Ethyl(2Z)-chloro((4-methoxyphenyl)hydrazono)acetate

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
ethyl (2Z)-2-chloro-2-[(4-methoxyphenyl)hydrazinylidene]acetate
2.1.2 InChI
InChI=1S/C11H13ClN2O3/c1-3-17-11(15)10(12)14-13-8-4-6-9(16-2)7-5-8/h4-7,13H,3H2,1-2H3/b14-10-
2.1.3 InChI Key
ATNPZEGMKLGIFA-UVTDQMKNSA-N
2.1.4 Canonical SMILES
CCOC(=O)C(=NNC1=CC=C(C=C1)OC)Cl
2.1.5 Isomeric SMILES
CCOC(=O)/C(=N/NC1=CC=C(C=C1)OC)/Cl
2.2 Synonyms
2.2.1 Depositor-Supplied Synonyms

1. 27143-07-3

2. Ethyl Chloro[(4-methoxyphenyl)hydrazono]acetate

3. Ethyl (2z)-2-chloro-2-[(4-methoxyphenyl)hydrazinylidene]acetate

4. Ethyl 2-chloro-2-(2-(4-methoxyphenyl)hydrazono)acetate

5. 473927-63-8

6. Ethyl Chloro((4-methoxyphenyl)hydrazono)acetate

7. Chloro[(4-methoxyphenyl)hydrazono]acetic Acid Ethyl Ester

8. Mfcd02852962

9. Acetic Acid, 2-chloro-2-[2-(4-methoxyphenyl)hydrazinylidene], Ethyl Ester

10. Cs-m1832

11. Zinc97947787

12. Akos015951073

13. Ac-26372

14. As-19748

15. Am20090751

16. Ethyl [(4-methoxyphenyl)hydrazono]-chloroacetate

17. A846990

18. J-520020

19. J-520727

20. (z)-ethyl2-chloro-2-(2-(4-methoxyphenyl)hydrazono)acetate

21. Acetic Acid, 2-chloro-2-[2-(4-methoxyphenyl)hydrazinylidene]-, Ethyl Ester

22. Ethyl (z)-2-chloro-2-[2-(4-methoxyphenyl)hydrazin-1-ylidene]acetate

23. Acetic Acid, 2-chloro-2-[2-(4-methoxyphenyl)hydrazinylidene], Ethyl Ester;(z)-ethyl 2-chloro-2-(2-(4-methoxyphenyl)hydrazono)acetate

2.3 Create Date
2007-02-07
3 Chemical and Physical Properties
Molecular Weight 256.68 g/mol
Molecular Formula C11H13ClN2O3
XLogP34.1
Hydrogen Bond Donor Count1
Hydrogen Bond Acceptor Count5
Rotatable Bond Count6
Exact Mass256.0614700 g/mol
Monoisotopic Mass256.0614700 g/mol
Topological Polar Surface Area59.9 Ų
Heavy Atom Count17
Formal Charge0
Complexity276
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count1
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1
Flag China
Digital Content Digital Content
URL Supplier Web Content
27143-07-3
Founded in 2003, Senary Chem is one of the Key High-Tech Enterprises of National Torch Plan. Senary locat...
Founded in 2003, Senary Chem is one of the Key High-Tech Enterprises of National Torch Plan. Senary located in National Cangzhou Lingang Economic and Technological Development Zone,Cangzhou City,Hebei Province. Senary cover an area of 67,000 square meters, and 300 professionals work there. Senary R&D organization recognized as the Hebei Provincial Engineering Technology Center is comprised of two R & D centers in Tianjin and Cangzhou, and it employs 80 experienced scientists in total. Senary focus on the development, production and sales of advanced pharmaceutical intermediates. Especially, Senary has leading technology and manufacturing capacity for diabetes drug intermediates. All intermediates of DPP4 and SGLT2 class drugs on market have been commercialized production. Senary has 150 sets of 50 ~ 8000L reactor with annual production capacity of 1,000 tons, which can handle both low and high temperature reactions within -100 ~ 240 ℃ range, all kinds of catalytic reactions within 0 ~ 5MPa pressure, and moisture and/or oxygen sensitive reactions. Senary also has expertise in chiral synthesis with leading technologies. The advanced sewage treatment system at Senery has processing capacity of 600 tons daily. Senary has an excellent team that has rich quality management experience.We have established a set of normative and perfect quality managment system,monitoring the whole process of risk assessment,R&D,transfer from pilot scale to commercial production,manufacturing,analysis and sales service. Senary will continue to dedicate on the field of pharmaceutical intermediates to provide the best service for domestic and foreign API pharmaceutical companies with high quality and timely supply of products.
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY